By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – OvaGene Oncology today announced it has completed licensing agreements with Norwegian researchers to validate new genomic technologies with the intention of developing them into clinical laboratory tests.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.
The New York Times reports on the shifting interpretations of what some genetic variants mean over time.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.
This webinar will address a range of methods for optimizing small RNA library preparation.
With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.
This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.